The present study demonstrated that irbesartan, a second‐generation ARB metabosartan, reduced renal and cardiac fibrosis induced by aldosterone treatment, a model of salt‐sensitive hypertension, in AT1aR KO mice. Here, AGTR1 is linked to fibrosis.